QUESTEX

A look back at our top stories of 2024 sees them fall into two major themes: promise, and a realignment of expectations... Phase 2 trial data will continue to be the name of the game when it comes to VC investments into biopharma in 2025, according to PitchBook... Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R

Also known as: Questex LLC